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The major component in green tea polyphenols, epigallocatechin-3-gallate (EGCG), has been demonstrated to
prevent carcinogenesis. To improve the effectiveness of EGCG, liposomes were used as a carrier in this study.
Reverse-phase evaporation method besides response surface methodology is a simple, rapid, and beneficial
approach for liposome preparation and optimization. The optimal preparation conditions were as follows:
phosphatidylcholine-to-cholesterol ratio of 4.00, EGCG concentration of 4.88 mg/mL, Tween 80 concentration of
1.08 mg/mL, and rotary evaporation temperature of 34.51°C. Under these conditions, the experimental encapsulation
efficiency and size of EGCG nanoliposomes were 85.79% ± 1.65% and 180 nm ± 4 nm, which were close with the
predicted value. The malondialdehyde value and the release test in vitro indicated that the prepared EGCG
nanoliposomes were stable and suitable for more widespread application. Furthermore, compared with free EGCG,
encapsulation of EGCG enhanced its inhibitory effect on tumor cell viability at higher concentrations.
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Epigallocatechin-3-gallate (EGCG) is the major and most
active constituent in green tea [1]. A number of studies
reported that EGCG had significant bioactivities such as
anticancer [2,3], prevention of cardiovascular disease [4],
and regulation of endocrine [5] and immune system [6].
EGCG has great potential in cancer prevention because
of its safety, low cost, and bioavailability [7,8]. Some re-
search results verified that encapsulated EGCG retained
its bioactivity such as inducing apoptosis of Du145 pros-
tate cancer cells.
One of the significant efforts towards these aims has
been the use of colloidal delivery systems such as lipo-
somes and micro or nanoparticles [9,10]. There have* Correspondence: rongfaguan@163.com; biomed528@163.com
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in any medium, provided the original work is pbeen considerable research works on the liposomes' ap-
plication of protection in food and pharmacy system
[11-13]. Besides, nanoliposomes have been demonstrated
to possess the advantages of improving the targeting and
absorption into the intestinal epithelial cells [14]. In this
study, nanoliposomes could be used as potential carriers
in the food system. Nanoliposomes with chemotherapeu-
tic agents can target tumor cells either passively or ac-
tively. Passive targeting exploits the characteristic features
of tumor biology that allow nanoliposomes to accumulate
in the tumor by enhanced permeability and retention ef-
fect. Active targeting achieves this by conjugating nanoli-
posomes containing chemotherapeutics with molecules
that bind to overexpressed antigens or receptors on the
target cells [15]. Nanoliposomes can increase the absorp-
tion of EGCG with their ability to deliver poorly soluble
drugs effectively [16]. Nanoliposomes entrap hydrophilic
EGCG and use the overexpression of fenestrations in can-
cer neovasculature to increase EGCG concentration at
tumor sites and control its release [17].Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Independent variables and their levels in the
experimental design
Independent variables Symbols Code levels
−1 0 1
PC/CH (w/w) X1 3 4 5
EGCG concentration (w/v) X2 4 5 6
Tween 80 concentration (w/v) X3 0.5 1 1.5
Rotary evaporation temperature (°C) X4 30 35 40
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nique used to empirically derive functional relationship
between one or more than one experimental response and
a set of input variables [18]. Furthermore, it may deter-
mine the optimum level of experimental factors required
for the given response(s). Response surface methodology
has been successfully used to model and optimize bio-
chemical and biotechnological processes related to food
[19,20]. Zhang et al. studied phosphatidylcholine propor-
tion, cholesterol proportion, and lipids/drug ratio on pre-
paring the nobiliside A liposome [21]. A similar trend has
been reported for gypenoside liposome [22].
The main objective of this study aimed at knowing the
effect of the ratio of phosphatidylcholine and cholesterol
(w/w), EGCG and Tween 80 concentration (w/v) (Sigma-
Aldrich, St. Louis, MO, USA), and the preparation tech-
niques of EGCG nanoliposomes such as rotary evapor-
ation temperature (°C) on the encapsulation efficiency and
size in order to find out the optimal conditions for prepar-
ing the EGCG nanoliposomes using RSM. Nanoliposomes
were tested in vitro for their stability in simulated gastro-
intestinal juice. Furthermore, EGCG nanoliposomes were
used to evaluate the cellular uptake, and their effects on
tumor cells were also investigated.
Methods
Materials
EGCG was purchased from Xiecheng Biotechnology Com-
pany (Hangzhou, China). Phosphatidylcholine (PC) and
cholesterol (CH) were purchased from Beijing Shuangxuan
Microorganism Co. Ltd (Beijing, China). Chloroform
and diethyl ether were obtained from Hangzhou Jiachen
Chemical Company (Hangzhou, China). All other chemi-
cals were of reagent grade. The water used for all experi-
ments was distilled twice through an all-glass apparatus.
Preparation of EGCG nanoliposomes
EGCG nanoliposomes were prepared by reverse-phase
evaporation method [23,24]. Briefly, a certain amount of
PC and CH was dissolved in chloroform-diethyl ether,
and EGCG was dissolved in a phosphate-buffered solu-
tion (PBS; 0.20 M, pH 7.4). The organic phase was
mixed with the aqueous phase by probe sonication for
5 min. The mixture was placed in a round-bottom flask,
and a gel was formed by evaporating the organic solvent
under reduced pressure using a rotary evaporator. Then,
30-mL phosphate-buffered solution containing Tween
80 was added and evaporated for another 20 min.
Encapsulation efficiency determination
The encapsulation efficiency (EE) of EGCG nanolipo-
somes was calculated to determine the concentration of
entrapped EGCG in nanoliposome and unentrapped
EGCG in the aqueous phase. Respectively, the EGCGnanoliposomes were separated from the aqueous phase
using a freeze centrifuge (GL 20A, Sorvall Biofuge Stratos
Co., Fisher Scientific, Leicestershire, England). A 0.5-mL
liposome suspension was taken and spun at 13,000 rpm
for 30 min at 4°C. The same suspension was ruptured
using sufficient volume of ethanol, and the total amount
of EGCG was determined spectrophotometrically.
The percentage of encapsulating efficiency (EE%) was
calculated according to Equation 1 [25].
EE% ¼W 2−W 1
W 2
 100; ð1Þ
where W1 is the amount of free EGCG, and W2 is the total
amount of EGCG present in 0.5 mL of nanoliposomes.
Particle size
The mean vesicle size of the nanoliposomes was measured
by a laser scattering method (Nano ZS 90, Malvern, UK).
Liposomal suspensions were diluted 100-fold with double-
distilled water before the measurement. The determination
was repeated three times per sample for three samples.
Experimental design and optimization
RSM as a generic method for optimization was applied
to optimize the formulation of EGCG nanoliposomes.
The optimization was designed based on a four-factor
Box-Behnken design with a total of 27 experimental
runs. Based on the preliminary experiments and our pre-
vious studies, four formulation parameters which in-
cluded PC/CH ratio (X1), EGCG concentration (X2),
Tween 80 concentration (X3), and rotary evaporation
temperature (X4) were identified as key factors respon-
sible for the EE and size. In view of the feasibility of lipo-
some preparation, the ranges of the four factors were
determined as follows: PC/CH (3 to 5, w/w), EGCG con-
centration (4 to 6, w/v), Tween 80 concentration (0.5 to
1.5, w/v), and rotary evaporation temperature (30°C to
40°C) (Table 1). The response could be related to the se-
lected variables by a second-order polynomial model. In
this study, a second-order polynomial (Equation 2) was
used to generate response surfaces.
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the coded values of independent variables, β0 is the inter-
cept coefficient, βi are the linear coefficients, βii are the
squared coefficients, and βij are the interaction coefficients
[26]. Statistical significance of the terms in the regression
equations was examined. The significant terms in the
model were found by analysis of variance (ANOVA) for
each response. The adequacy of the model was checked
accounting for R2 and adjusted R2. The desired goals for
each variable and response were chosen. All the independ-
ent variables were kept within the range while the re-
sponses were either maximized or minimized.
Malondialdehyde value
EGCG nanoliposomes were stored in a refrigerator at 4°C
for 30 days. The malondialdehyde (MDA) value was de-
termined as an index of the phospholipid peroxidation
[27]. The MDA value was detected spectrophotometric-
ally by thiobarbituric acid (TBA) reaction following theTable 2 ANOVA and regression coefficients of the second-ord
(actual values)
Source DF EE (%)
Coefficient Sum of squares
Model 14 84.31 5,214.51
Linear
X1 1 −3.44 142.35
X2 1 −5.18 321.99
X3 1 5.25 331.07











X1 X2 −9.68 374.81
X1 X3 17.60 1,238.34
X1 X4 4.45 79.30
X2 X3 5.17 106.81
X2 X4 −0.17 0.12
X3 X4 −2.56 26.11
Residual 12 220.91
Lack of fit 10 214.09




CV 7.43method of Weng and Chen [28]. Taking 5 mL of a mixture
of 25 mmol/L TBA, 0.9 mol/L TCA and 50 mmol/L HCl
in a test tube and 1 mL EGCG nanoliposomes were
heated to 100°C for 30 min, and after reaching room
temperature, the absorbance of the solutions was mea-
sured at 532 nm [29].
In vitro release of EGCG from nanoliposomes
The controlled release was examined in simulated gas-
tric juice of pH 1.3 and intestinal juice of pH 7.5. The
solution of pH 1.3 consisted of HCl (0.10 M), pepsin,
and deionized water, while the solution of pH 7.5 was
made up of KH2PO4 (6.8 mg/mL), NaOH (0.10 M, ad-
justed to pH 7.5), trypsin (10 mg/mL), and deionized
water [30]. Five milliliters of EGCG nanoliposome sus-
pensions was mixed with the equal volume of simulated
gastrointestinal juice in a 50-mL beaker. The beaker was
placed on a magnetic stirrer adjusted to a constant speed
of 150 rpm at 37°C. Aliquots of 0.2 mL were sampleder polynomial model for the response variables
Size (nm)
p value Coefficient Sum of squares p value
<0.0001 182.33 17,393.67 <0.0001
0.0166 0.58 4.08 0.7894
0.0013 6.42 494.08 0.0110
0.0011 −5.08 310.08 0.0348
0.0815 −5.25 330.75 0.0302
<0.0001 −34.87 6,486.75 <0.0001
<0.0001 2.63 36.75 0.4286
<0.0001 −22.88 2,790.75 <0.0001
<0.0001 −17.88 1,704.08 0.0001
0.0007 −8.50 289.00 0.0404
<0.0001 −6.00 144.00 0.1308
0.0601 26.25 2,756.25 <0.0001
0.0330 −9.25 342.25 0.0279
0.9372 24.50 2,401.00 <0.0001
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EGCG from nanoliposomes was evaluated by a release ra-
tio. The release ratio was calculated using Equation 3 [31].




where EE0 is the encapsulation efficiency of EGCG
nanoliposomes before incubation, and EEt is the encap-
sulation efficiency of EGCG nanoliposomes after incuba-
tion for the time.
Cellular uptake studies
Cell viability was determined by methyl thiazolyl tetrazo-
lium (MTT) reduction assay [32,33]. Caco-2 cells (CBCAS,
Shanghai, China) were cultured in DMEM (Gibco,
Gaithersburg, MD, USA). The cells were cultured at
37°C with 5% CO2 [34]. The cells were passaged thrice
a week. At 80% confluence, the cells were subcultured
into 96-well plates. After the monolayer of cells be-
came formed for 36 h, the cells were treated with a
range of concentrations of different EGCG nanoliposomes
and EGCG. The cells were treated with the described par-
ticle suspensions for 24 h. Cell activity was determined by
measuring the enzymatic reduction of yellow tetrazolium
MTT to a purple formazan, as measured at 570 nm using
an enzyme-labeled instrument [35].
Statistical analysis
The results were expressed as mean ± standard deviation of
three independent experiments. Values of p > 0.05, p < 0.05,
and p < 0.01 were considered not significant, significant,Figure 1 Response surface for the effects of independent variables on
phosphatidylcholine-to-cholesterol ratio and EGCG concentration were sho
concentration = 1 mg/mL); the effects of rotary evaporation temperature an
to-cholesterol ratio = 4 and EGCG concentration = 5 mg/mL).and extremely significant, respectively. SPSS 16.0 software
was used for the statistical analysis.
Results and discussion
Fitting the model
For the corresponding fitting of the explanatory models,
the variations of encapsulation efficiency and size were
analyzed. These analyses indicated that adding terms up
to quadratic significantly improved the model (Table 1)
and could be the most appropriate model for the re-
sponse variable.
Regression analysis and the analysis of variance (ANOVA)
were used for fitting the model and to examine the stat-
istical significance of the terms. The estimated regres-
sion coefficients for the response variable, along with
the corresponding R2, adjusted R2 (adj-R2), F value, and
p value of lack of fit, were shown in Table 2.
The lack of fit showed that the models failed to repre-
sent the data in the experimental domain at which
points were not included in the regression. The lack of
fit of the EE and size were 0.15 and 0.20, respectively,
which were not significant (p > 0.05) for the response
surface model, meaning that the model represented the
data accurately.
The R2 values for the response variable of the EE and
size were both 0.96 which were higher than 0.80, indicat-
ing that the regression models were suitable to explain
the behavior, but a large value of R2 does not always
imply the adequacy of the model. Adding a variable to
the model will always increase R2, regardless of whether
the additional variable is statistically significant or not.
Thus, it is better to use an adj-R2 to evaluate the model
adequacy. The R2 and adj-R2 values for the model didencapsulation efficiency of EGCG nanoliposomes. The effects of
wn in (A) (rotary evaporation temperature = 35°C and Tween 80
d Tween 80 concentration were shown in (B) (phosphatidylcholine-
Figure 2 Response surface for the effects of independent variables on the size of EGCG nanoliposomes. The effects of phosphatidylcholine-
to-cholesterol ratio and Tween 80 concentration were shown in (A) (EGCG concentration = 5 mg/mL and rotary evaporation temperature = 35°C); the
effects of EGCG concentration and rotary evaporation temperature were shown in (B) (phosphatidylcholine-to-cholesterol ratio = 4 and Tween
80 concentration = 1 mg/mL).
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have not been included in the model.Table 3 Predicted optimum conditions for the
preparation of EGCG nanoliposomes
Factor Low High Optimum
Phosphatidylcholine/cholesterol 3 5 4
EGCG concentration (mg/mL) 4 6 4.88
Tween 80 concentration (mg/mL) 0.5 1.5 1.08
Rotary evaporation temperature (°C) 30 40 34.51Encapsulation efficiency
The p values were used as a tool to check the signifi-
cance of every coefficient. The smaller the magnitude of
p is, the more significant the corresponding coefficient
is. Values of p less than 0.05 indicate that model terms
are significant.
The results in Table 2 showed that the linear effects
of phosphatidylcholine-to-cholesterol ratio, EGCG con-
centration, and Tween 80 concentration were signifi-
cant (p < 0.05), whereas rotary evaporation temperature
was not significant. The effects of the independent variables
on EGCG nanoliposomes were shown in Figure 1. Accord-
ing to Figure 1A, increasing the phosphatidylcholine-to-
cholesterol ratio increased the encapsulation efficiency. It
might be due to the fact that cholesterol can change the
order of mobility of lecithin in the lipid bilayer, thus re-
inforcing the membrane stability. On the other hand,
increasing the EGCG concentration increased the en-
capsulation efficiency. At higher EGCG concentration,
the encapsulation efficiency was enhanced because more
EGCG was encapsulated into the vesicles.
As shown in Figure 1B, the increase in Tween 80 con-
centration led to the increase in the EE of EGCG nanoli-
posomes. This increased EE may be attributed to the
increase in densification of liposome surface due to the
availability of lipophilic ambience, which could accommo-
date EGCG to a higher extent [36]. The results indicated
the higher level of phosphatidylcholine-to-cholesterol ra-
tio and EGCG and Tween 80 concentrations increased
the encapsulation efficiency.Particle size
The p values were used as a tool to check the signifi-
cance of every coefficient. The smaller the magnitude of
p is, the more significant the corresponding coefficient
is. Values of p less than 0.05 indicate that model terms
are significant.
The results in Table 2 showed that based on the sum of
squares, the importance of the independent variables on
yield could be ranked in the following order: EGCG con-
centration > rotary evaporation temperature > Tween 80
concentration > phosphatidylcholine-to-cholesterol ratio.
The variation of size with the phosphatidylcholine-
to-cholesterol ratio and Tween 80 concentration is
presented in Figure 2A. The particle size of the EGCG
nanoliposomes decreased with decreasing phosphat-
idylcholine concentration because phospholipids consti-
tute the liposome membrane and phosphatidylcholine
concentration directly affected the particle size of the
liposome.
The effect of the EGCG concentration and rotary
evaporation temperature on the nanoliposome size is
given in Figure 2B. The rotary evaporation temperature
had an effect on the size of the liposomes. Zhou et al. re-
ported that during the preparation, the lipid solution
Table 4 Predicted and experimental values of the
responses obtained at optimum conditions
Response Predicted value Experimental value
EE (%) 85.14 85.79 ± 1.65
Size (nm) 181 180 ± 4
Results are shown as the mean ± SD (n = 3).
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the gemcitabine liposome injection [37]. Besides, it has
also been cited that different EGCG concentrations have
an effect on the particle size and dispersion of the lipo-
some. Similar trend has been reported for paclitaxel
magnetic nanoparticle liposome [38].
Optimization
After the effects of PC/CH, EGCG concentration, Tween
80 concentration, and rotary evaporation temperature
on the formulation of EGCG nanoliposomes were inves-
tigated, the optimum ranges for each independent vari-
able were found to generate EGCG nanoliposomes with
the highest EE and small size. The optimum formulation
conditions were as follows (Table 3): phosphatidylcholine-
to-cholesterol ratio of 4.00, EGCG concentration of
4.88 mg/mL, Tween 80 concentration of 1.08 mg/mL, and
rotary evaporation temperature of 34.51°C. The conditions
gave the highest encapsulation efficiency (85.79% ± 1.65%)
with the low value of the particle size (180 nm± 4 nm),
and the experimental values were close to the predicted
values (Table 4), which indicated that the optimized
preparation conditions were very reliable. EGCG nano-
liposomes of optimized formulation were used for the
determination of particle size distribution (Figure 3). The
results indicated that the model used can identify operat-
ing conditions for preparing EGCG nanoliposomes.
Malondialdehyde value
Phospholipid was used as the major component of lipo-
somal membrane, containing partially polyunsaturated
fatty acid residues sensitive to oxidative free radicals
[39]. The MDA, which is a final product of fatty acid
peroxidation, was evaluated in the study. During 30 days
of storage at 4°C, the MDA values in the EGCGFigure 3 The particle size of the optimized EGCG nanoliposomes.nanoliposomes showed no distinct differences (p > 0.05)
in the MDA values which were shown in Figure 4. The
result showed the EGCG nanoliposomes could be stable
in a period of time in fatty acid peroxidation field. Simi-
lar results were observed in some studies [40]. Addition-
ally, to consummate stability research, storage stability,
effect of sonication, and other aspects which also evalu-
ate the stability of the nanoliposomes with respect to
variations in their pH and leakage rates are ongoing.
In vitro release of EGCG from nanoliposomes
When EGCG nanoliposomes could be used as carriers
for the oral administration of EGCG, they must be able
to withstand passage through the stomach and small in-
testine. In vitro release has been used as a very import-
ant surrogate indicator of in vivo performance. Guan
et al. have found that 23% and about 37% of lactoferrin
released from nanoliposomes in the simulated gastric/
intestinal juice were considered to be stable [40]. In vitro
release profiles of EGCG from nanoliposomes were
shown in Figure 5. About 21% EGCG was released from
nanoliposomes within 4 h in the simulated gastric juice.
The instability of the nanoliposomes would be related to
the permeation of protons, and the release of EGCG
from nanoliposomes in the simulated gastric juice may
be due to the low pH [41]. However, because food usu-
ally remains in the stomach for more or less 4 h, the li-
posomal EGCG could be effectively protected in the
gastric juice. In simulated intestinal juice, bile salts and
pancreatic lipase may cause the EGCG release from
nanoliposomes [42]. This effect may increase the release
of nanoliposome. The nanoliposomes showed an accept-
able stability and may be fit for use in the oral administra-
tion [43]. Previous studies suggested that many liposome
compositions used were unstable in the conditions pre-
vailing in the gastrointestinal tract through in vitro tests
[44,45]. It has been demonstrated that liposomes were
pinocytosed by intestinal epithelial cells and transferred to
the serosal side of the gut by means of more stable lipo-
somes in an everted gut system [46]. Our study on EGCG
nanoliposomes has shown that there may be the possibil-
ity of enhancing the uptake process to deliver a range of
Figure 6 Cell viability of Caco-2 cells treated with different
concentrations of EGCG nanoliposomes and EGCG. Data reported
are the mean values ± standard variation of three replications.
(** p < 0.01, compared with the first group).
Figure 4 Variation of the MDA values in EGCG nanoliposomes
during storage at 4°C for 30 days. Data reported are the mean
values ± standard variation of three replications.
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which affect absorption efficiency in the stomach and in-
testine should be determined as an index of the stability of
nanoliposomes.
Cell viability
After the cells were incubated with 0.5, 1, 2.5, 5, and
10 mg/mL of EGCG nanoliposomes for 24 h, they were
compared with the control experiments. Figure 6 showed
that the MTT results demonstrated a concentration-
dependent uptake after exposure to EGCG nanolipo-
somes. With the same concentration, the cell activity of
the EGCG nanoliposomes was lower than the cell activity
of EGCG. IC50s of EGCG and EGCG nanoliposomes were
6.13 and 1.47 mg/mL, respectively. The MTT results
showed that EGCG nanoliposomes and EGCG activated
in the cells in a manner of dose-effect relation and EGCG
nanoliposomes had a more obvious function to the tumor
cells (p < 0.01) without affecting normal cell viability. The
possibility of both targeting drugs to specific tissues and
cells and facilitating their uptake and cytoplasmic delivery
had rendered liposomes a versatile drug carrier system
with numerous potential applications [47], which wereFigure 5 The effect of simulated gastrointestinal juice on EGCG
nanoliposomes. Data reported are the mean values ± standard
variation of three replications.expected to increase the efficiency and effectiveness of the
drug as well as enable the use of new (and more potent)
drugs [48]. In the latter application, reducing the particle
size of nanoliposomes may be an efficient and reliable tool
for improving the bioavailability and absorption in food
and medicine [49].Conclusions
The effects of the phosphatidylcholine-to-cholesterol ra-
tio, concentration of EGCG and Tween 80, and rotary
evaporation temperature on preparing EGCG nanolipo-
somes were studied. A second-order polynomial model
was obtained for predicting the encapsulation efficiency
and size. Increasing the phosphatidylcholine-to-cholesterol
ratio, EGCG concentration, and Tween 80 concentration in-
creased the encapsulation efficiency. Numerical optimization
determined the optimum preparation conditions, which
were the phosphatidylcholine-to-cholesterol ratio of
4.00, EGCG concentration of 4.88 mg/mL, Tween 80
concentration of 1.08 mg/mL, and rotary evaporation
temperature of 34.51°C. Under these conditions, the ex-
perimental encapsulation efficiency and size of the EGCG
nanoliposomes were 85.79% ± 1.65% and 180 nm± 4 nm,
which were close with the predicted value. Therefore, the
optimized preparation conditions were very reliable. The
value of MDA indicated the stability of the EGCG nanoli-
posomes suspension. Furthermore, nanoliposomes were
tested in vitro for their stability in simulated gastrointes-
tinal juice. The results indicated that the prepared EGCG
nanoliposomes were stable and may be fit for use in the
oral administration. The cellular uptake of the EGCG
nanoliposome formulations were found to depend on the
concentration. In conclusion, we have demonstrated that
EGCG nanoliposomes with different concentrations could
modulate the growth of tumor cells and were suitable for
more widespread application.
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